Related Experiment Videos
Transcatheter embolization of pelvic vessels to stop intractable hemorrhage
Insights
Transcatheter embolization effectively treated severe vaginal bleeding in four of six patients. This interventional radiology technique showed promise for gynecologic bleeding, including rare cases of metastatic gestational trophoblastic disease.
Area of Science:
- Interventional Radiology
- Gynecologic Oncology
- Vascular Embolization
Background:
- Severe vaginal bleeding poses significant clinical challenges.
- Management options for intractable gynecologic hemorrhage are limited.
- Gestational trophoblastic disease (GTD) can present with rare vaginal metastases.
Purpose of the Study:
- To evaluate the efficacy of transcatheter embolization for severe vaginal bleeding.
- To assess the safety and outcomes of embolization in gynecologic malignancies and GTD.
- To report on a novel application of embolization for vaginal metastases in GTD.
Main Methods:
- Transcatheter arterial embolization of selected pelvic vessels was performed in six patients.
- Patients included those with cervical cancer, dysfunctional uterine bleeding, and GTD with vaginal metastases.
- Embolization aimed to occlude bleeding pelvic vessels.
Main Results:
- Successful hemostasis was achieved in four out of six patients.
- Two cases experienced treatment failure, with reasons detailed.
- This study includes the first reported cases of embolization for vaginal metastases in GTD.
Conclusions:
- Transcatheter embolization is a viable option for managing severe vaginal bleeding in gynecologic conditions.
- The procedure demonstrated effectiveness in a majority of treated patients.
- Further research is warranted, particularly for rare indications like metastatic GTD.
Abstract:
Six patients with severe vaginal bleeding were treated with transcatheter embolization of selected pelvic vessels. Three patients had Stage III(b) carcinoma of the cervix, one with dysfunctional uterine bleeding and two patients had gestational trophoblastic disease (GTD) with bleeding from vaginal metastases. Bleeding stopped in four of the six cases. Reasons for failure in the other two cases are given. No other reports of bleeding from vaginal metastases in metastatic GTD treated in this way have been seen in the literature.